» Articles » PMID: 34202641

Cohesin Mutations in Cancer: Emerging Therapeutic Targets

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 2
PMID 34202641
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The cohesin complex is crucial for mediating sister chromatid cohesion and for hierarchal three-dimensional organization of the genome. Mutations in cohesin genes are present in a range of cancers. Extensive research over the last few years has shown that cohesin mutations are key events that contribute to neoplastic transformation. Cohesin is involved in a range of cellular processes; therefore, the impact of cohesin mutations in cancer is complex and can be cell context dependent. Candidate targets with therapeutic potential in cohesin mutant cells are emerging from functional studies. Here, we review emerging targets and pharmacological agents that have therapeutic potential in cohesin mutant cells.

Citing Articles

Fdo1, Fkh1, Fkh2, and the Swi6-Mbp1 MBF complex regulate Mcd1 levels to impact eco1 rad61 cell growth in Saccharomyces cerevisiae.

Singh G, Skibbens R Genetics. 2024; 228(2).

PMID: 39110836 PMC: 11457938. DOI: 10.1093/genetics/iyae128.


Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer.

Carey-Smith S, Kotecha R, Cheung L, Malinge S Int J Mol Sci. 2024; 25(13).

PMID: 38999925 PMC: 11241182. DOI: 10.3390/ijms25136815.


IFIT1 + neutrophil is a causative factor of immunosuppressive features of poorly cohesive carcinoma (PCC).

Liu Y, Li J, Han M, Li J, Ye Q, Lin S J Transl Med. 2024; 22(1):580.

PMID: 38898490 PMC: 11188200. DOI: 10.1186/s12967-024-05389-z.


Synthetic Lethality between Cohesin and WNT Signaling Pathways in Diverse Cancer Contexts.

Pallotta M, Di Nardo M, Musio A Cells. 2024; 13(7.

PMID: 38607047 PMC: 11011321. DOI: 10.3390/cells13070608.


Chromatin organization in myelodysplastic syndrome.

Xu J, Viny A Exp Hematol. 2024; 134:104216.

PMID: 38582293 PMC: 11152986. DOI: 10.1016/j.exphem.2024.104216.


References
1.
Rhodes J, Feldmann A, Hernandez-Rodriguez B, Diaz N, Brown J, Fursova N . Cohesin Disrupts Polycomb-Dependent Chromosome Interactions in Embryonic Stem Cells. Cell Rep. 2020; 30(3):820-835.e10. PMC: 6988126. DOI: 10.1016/j.celrep.2019.12.057. View

2.
Uuskula-Reimand L, Hou H, Samavarchi-Tehrani P, Vietri Rudan M, Liang M, Medina-Rivera A . Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders. Genome Biol. 2016; 17(1):182. PMC: 5006368. DOI: 10.1186/s13059-016-1043-8. View

3.
Schuster K, Leeke B, Meier M, Wang Y, Newman T, Burgess S . A neural crest origin for cohesinopathy heart defects. Hum Mol Genet. 2015; 24(24):7005-16. PMC: 4654055. DOI: 10.1093/hmg/ddv402. View

4.
Tomkins D, Sisken J . Abnormalities in the cell-division cycle in Roberts syndrome fibroblasts: a cellular basis for the phenotypic characteristics?. Am J Hum Genet. 1984; 36(6):1332-40. PMC: 1684655. View

5.
Olley G, Ansari M, Bengani H, Grimes G, Rhodes J, von Kriegsheim A . BRD4 interacts with NIPBL and BRD4 is mutated in a Cornelia de Lange-like syndrome. Nat Genet. 2018; 50(3):329-332. PMC: 6469577. DOI: 10.1038/s41588-018-0042-y. View